Antibody-Drug Conjugates Market: Detailed Insights, Target Population, Competitive Landscape, and 2034 Forecast
Antibody-drug conjugates are a groundbreaking innovation in cancer treatment, combining monoclonal antibodies with potent cytotoxic agents to deliver highly targeted therapies. This approach enhances therapeutic efficacy while reducing systemic toxicity, positioning antibody-drug conjugates as a pivotal advancement in on